Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationFull details have been published today of the refreshed UK-wide Innovative Licensing and Access Pathway (ILAP), that will offer a clearer, more streamlined and integrated process for developers to help get transformative new medicines to patients in the National Health Service (NHS) in the shortest time possible.
The ICH E6(R3) Introductory Training Presentation is now available on the ICH website
ICH E6(R3) (Principles and Annex 1), has reached Step 5 and will be effective from June 2025, and adopted on the 23rd July. ICH E6 (R2) remains in effect until 11 June 2025.
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 January 2025
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025
Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines - published 20th Jan 2025.
The African Union Development Agency - New Partnership for Africa's Development (AUDA-NEPAD) becomes a new PIC/S Associated Partner Organisation
US intends to withdraw from WHO
19th-20th February 2025
The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024: guidance on implementation Medical devices: periodic safety update report (PSUR)